Major electronic health records vendors insist they are successfully responding to the needs of the emerging field of clinical genomics, despite barriers including uncertainly about who pays for genomic testing, lack of data standardization, and the general slow pace of change in healthcare.
“We’ve worked closely with our customers, with genetic testing labs, and standards bodies … to go beyond the PDF results report and actually bring discrete genetic testing data into Epic,” said Catherine Procknow, genomics product lead at Epic Systems.
Bob Robke, VP of clinical enterprise at Cerner, said that the healthcare industry in general is still struggling to understand how to incorporate genomics into patient care. Robke noted that pharmacogenomics has not had the uptake he had hoped because providers frequently have issues regarding who will pay for testing. “When we start seeing that trend move, you’ll see us doing more innovation in [pharmacogenomics],” he said.